Published in Hum Reprod on March 28, 2008
Ovarian aging and premature ovarian failure. J Turk Ger Gynecol Assoc (2014) 0.79
Human Umbilical Cord Mesenchymal Stem Cells Therapy in Cyclophosphamide-Induced Premature Ovarian Failure Rat Model. Biomed Res Int (2016) 0.78
Early menopause: A hazard to a woman's health. Indian J Med Res (2016) 0.76
Prediction of assisted reproductive technique outcome in elevated early follicular phase follicle stimulating hormone with Mullerian inhibiting substance level. Iran J Reprod Med (2012) 0.75
Women with consistently or variably elevated early follicular phase FSH. Hum Reprod (2008) 0.75
Antagonist use in intrauterine insemination (IUI) cycles. J Turk Ger Gynecol Assoc (2009) 0.75
[Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff]. Ned Tijdschr Geneeskd (2005) 5.28
A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update (2006) 4.24
Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod (2002) 3.59
The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ (2006) 3.27
[Cushing's syndrome. I. New diagnostic developments]. Ned Tijdschr Geneeskd (2006) 2.73
Deoxyribonucleic acid polymerase associated with avian tumor viruses: secondary structure of the deoxyribonucleic acid product. J Virol (1971) 2.47
Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology (1999) 2.42
Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab (2000) 2.36
Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet (2000) 2.33
Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology (2001) 2.28
Neurogenic pulmonary edema. Acta Anaesthesiol Scand (2007) 2.27
Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study. Hum Reprod (2013) 2.21
Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab (2011) 2.02
Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum (1998) 2.00
The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod (2006) 1.93
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Hum Reprod (2011) 1.80
Cortisol receptor resistance: the variability of its clinical presentation and response to treatment. J Clin Endocrinol Metab (1992) 1.72
Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum Genet (1997) 1.66
Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab (2005) 1.64
Adrenal glands of mouse and rat do not synthesize androgens. Life Sci (1992) 1.64
Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study. Hum Reprod (2011) 1.62
Relationship of serum antimüllerian hormone concentration to age at menopause. J Clin Endocrinol Metab (2008) 1.60
Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females. Clin Endocrinol (Oxf) (2005) 1.57
Intercycle variability of ovarian reserve tests: results of a prospective randomized study. Hum Reprod (2004) 1.51
Gender-specific relationship between serum free and total IGF-I and bone mineral density in elderly men and women. Eur J Endocrinol (1998) 1.51
Predictive value of basal follicle-stimulating hormone concentrations in a general subfertility population. Fertil Steril (2000) 1.49
Basal FSH concentrations as a marker of ovarian ageing are not related to pregnancy outcome in a general population of women over 30 years. Hum Reprod (2004) 1.48
Haemodynamic and neurohumoral effects of xenon anaesthesia. A comparison with nitrous oxide. Anaesthesia (1990) 1.44
Relationship between ovarian production of estrone, estradiol, testosterone, and androstenedione and the ovarian degree of stromal hyperplasia in postmenopausal women. Menopause (1998) 1.43
Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVF. J Assist Reprod Genet (2005) 1.42
Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease. Clin Endocrinol (Oxf) (1997) 1.41
'Pseudo-aldosteronism' induced by intravenous glycyrrhizin treatment of chronic hepatitis C patients. J Gastroenterol Hepatol (2001) 1.41
Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod (2009) 1.40
Etomidate suppresses adrenocortical function by inhibition of 11 beta-hydroxylation. J Clin Endocrinol Metab (1984) 1.39
Corticosteroid therapy in severe illness. N Engl J Med (1997) 1.38
Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum Reprod (2006) 1.35
Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab (2012) 1.35
Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. J Clin Endocrinol Metab (1998) 1.33
Altered hypothalamus-pituitary-adrenal gland axis regulation in the expanded CGG-repeat mouse model for fragile X-associated tremor/ataxia syndrome. Psychoneuroendocrinology (2008) 1.31
Influence of receptor number on functional responses elicited by agonists acting at the human adenosine A(1) receptor: evidence for signaling pathway-dependent changes in agonist potency and relative intrinsic activity. Mol Pharmacol (2000) 1.27
Evaluation of a radioimmunoassay for testosterone estimation. J Steroid Biochem (1973) 1.23
Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod Biomed Online (2008) 1.21
Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer. Lancet (1982) 1.20
Are GnRH antagonists comparable to agonists for use in IVF? Hum Reprod (2007) 1.20
Salivary cortisol is related to atherosclerosis of carotid arteries. J Clin Endocrinol Metab (2008) 1.18
Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone. Hum Reprod (2009) 1.17
Metabolomic profiling by near-infrared spectroscopy as a tool to assess embryo viability: a novel, non-invasive method for embryo selection. Hum Reprod (2008) 1.16
17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab (1999) 1.16
Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. Hum Reprod (2009) 1.15
A novel tool in the diagnosis and follow-up of (cyclic) Cushing's syndrome: measurement of long-term cortisol in scalp hair. J Clin Endocrinol Metab (2012) 1.14
Increased concentrations of follicle-stimulating hormone in mothers of children with Down's syndrome. Lancet (1999) 1.11
Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Hum Reprod (2008) 1.10
Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. Fertil Steril (1990) 1.07
An evaluation of etiologic factors and therapy in 665 infertile couples. Fertil Steril (1977) 1.07
Stromal cell-derived receptor 2 and cytochrome b561 are functional ferric reductases. Biochim Biophys Acta (2003) 1.06
Gonadotropin-releasing-hormone-receptor antagonists. Lancet (2001) 1.05
11beta-Hydroxysteroid dehydrogenase expression and glucocorticoid synthesis are directed by a molecular switch during osteoblast differentiation. Mol Endocrinol (2004) 1.05
A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly. J Clin Endocrinol Metab (1998) 1.04
Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study. Hum Reprod (2000) 1.04
Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. J Am Coll Cardiol (1998) 1.03
Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells. J Pharmacol Exp Ther (1987) 1.03
Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation. J Clin Endocrinol Metab (1992) 1.03
Interpretation of uroflowmetry curves by urologists. J Urol (1997) 1.01
Effect of gonadotrophins on the secretion of oestradiol- and testosterone by the rat testis. J Endocrinol (1973) 1.01
Inhibin: 1985 update on action and purification. Mol Cell Endocrinol (1985) 1.01
Plasma oestradiol-17beta and its relationship to serum follicle-stimulating hormone in immature female rats. J Endocrinol (1973) 1.01
Mutations in human gonadotropin and gonadotropin-receptor genes. Endocrine (2005) 1.01
Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases. Hum Reprod (2010) 1.00
Fluconazole inhibits human adrenocortical steroidogenesis in vitro. J Endocrinol (2012) 1.00
Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil Steril (1995) 0.99
Five patients with biochemical and/or clinical generalized glucocorticoid resistance without alterations in the glucocorticoid receptor gene. J Clin Endocrinol Metab (2000) 0.99
Differential hormone-dependent transcriptional activation and -repression by naturally occurring human glucocorticoid receptor variants. Mol Endocrinol (1997) 0.98
Basal FSH, estradiol and inhibin B concentrations in women with a previous Down's syndrome affected pregnancy. Hum Reprod (2002) 0.98
Estimating parametric relationships between health description and health valuation with an application to the EuroQol EQ-5D. J Health Econ (1999) 0.98
Heritability of reproductive hormones in adult male twins. Hum Reprod (2007) 0.97
Long-term effects of buserelin on plasma testosterone and luteinising hormone concentrations. Lancet (1985) 0.97
Castration-induced changes in morphology, androgen levels, and proliferative activity of human prostate cancer tissue grown in athymic nude mice. Prostate (1993) 0.97
Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome. Hum Reprod (2009) 0.97
The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review. Eur J Endocrinol (2013) 0.97
A reduced size of the ovarian follicle pool is associated with an increased risk of a trisomic pregnancy in IVF-treated women. Hum Reprod (2009) 0.95
No evidence that embryo selection by near-infrared spectroscopy in addition to morphology is able to improve live birth rates: results from an individual patient data meta-analysis. Hum Reprod (2014) 0.95
Aggrecanase and metalloproteinase-specific aggrecan neo-epitopes are induced in the articular cartilage of mice with collagen II-induced arthritis. Osteoarthritis Cartilage (1997) 0.95
Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve. Hum Reprod (2004) 0.95
Testosterone secretion by cultured arrhenoblastoma cells: suppression by a luteinizing hormone-releasing hormone agonist. J Clin Endocrinol Metab (1982) 0.95
Medical consumption and costs during a one-year follow-up of patients with LUTS suggestive of BPH in six european countries: report of the TRIUMPH study. Eur Urol (2005) 0.95
High neonatal triiodothyronine levels reduce the period of Sertoli cell proliferation and accelerate tubular lumen formation in the rat testis, and increase serum inhibin levels. Endocrinology (1993) 0.95
Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study. Hum Reprod (2003) 0.95